CAS: 204255-02-7; (1R,5R,6R)-Ethyl 5-(Pentan-3-Yloxy)-7-Azabicyclo[4.1.0]Hept-3-Ene-3-Carboxylate

该化合物是一种复杂的有机化合物,其特征是双环结构,其中包括环状系统中的氮原子,有助于将其分类为anzabilycolio化合物.一个箱状酸功能组的存在表明其潜在的酸性和再活动,而乙酯细胞则表明它可能参与酯变反应.一个被(1R,5R,6R)所注解的具体立体化学学表明,它环绕着手腔中心周围的原子空间安排,这可能会对化合物的生物活动和相互作用产生重大影响.这种化合物可能表现出双环状胺的典型特性,例如潜在的药理学影响,并且可能对医药化学产生兴趣.它的独特结构还可能赋予特定的溶性性和稳定性特性,使其适合在有机合成中应用,或作为潜在的药物候选物.进一步调查其物理和化学特性是必要的.

结构式图片

MSDS等安全信息

    上下游产品

    CAS号204254-96-6 5-(戊烷-3-基氧基)-7-... | CAS号204254-84-2 1,3-Benzodioxol... | CAS号77-95-2 D-(-)-奎宁酸 | CAS号77-76-9 2,2-二甲氧基丙烷 | CAS号196618-13-0 奥司他韦 | CAS号204255-11-8 磷酸奥司他韦 | CAS号204255-06-1 5-叠氮奥塞米韦

    合成工艺路线路线简述

      📜奥司他韦杂质58置于sodium Azide,三氟甲磺酸三甲基硅酯,Dimethyl Sulfide Borane,Ammonium Chloride,Potassium Hydrogencarbonate,三甲基膦体系中,化学反应 21.2H,反应生成(1R,5R,6R)-5-(1-乙丙基)-7-氮杂双环[4.1.0]庚-3-烯-3-羧酸乙酯
      参考文献:Practical Total Synthesis Of The Anti-Influenza Drug Gs-4104
      标题:Practical Total Synthesis Of The Anti-Influenza Drug Gs-4104
      摘要:
      Doi:10.1021/jo980330Q

      海关参考信息

      专利信息


      专利号:US-6518438-B2
      优先权日:1996-08-23
      标题:Preparation of cyclohexene carboxylate derivatives
      发明人:KENT KENNETH M; KIM CHOUNG U; MCGEE LAWRENCE R; MUNGER JOHN D; PRISBE ERNEST J; POSTICH MICHAEL J; ROHLOFF JOHN C; KELLY DAPHNE E; WILLIAMS MATTHEW A; ZHANG LIJUN
      权利人:GILEAD SCIENCES INC
      摘要:The present invention provides new synthetic methods and compositions. In particular, new methods of preparing intermediates useful in the synthesis of neuraminidase inhibitors and compositions useful as intermediates that are themselves useful in the synthesis of neuraminidase inhibitors are provided.

      专利号:US-9150498-B2
      优先权日:2011-10-25
      标题:Process for the preparation of oseltamivir and methyl 3-epi-shikimate
      发明人:RAWAT VARUN; DEY SOUMEN; ARUMUGAM SUDALAI
      权利人:COUNCIL SCIENT IND RES
      摘要:The present invention discloses high yielding enantioselective process for synthesis of Oseltamivir from readily available starting material, cis-1,4-butene diol. The process features incorporation of chirality using sharpless asymmetric epoxidation (AE) and diastereoselective Barbier allylation and construction of cyclohexene carboxylic acid ester core through a ring closing metathesis (RCM) reaction. Further also disclosed herein is synthesis of (−)-methyl 3-epi-shikimate.

      专利号:US-2004053999-A1
      优先权日:1997-09-17
      标题 :Novel compounds and methods for synthesis and therapy
      发明人:BISCHOFBERGER NORBERT W; DAHL TERRENCE C; HITCHCOCK MICHAEL J M; KIM CHOUNG U; LEW WILLARD; LIU HONGTAO; MILLS ROGER G; WILLIAMS MATTHEW A
      摘要:Novel compounds are described. The compounds generally comprise an acidic group, a basic group, a substituted amino or N-acyl and a group having an optionally hydroxylated alkane moiety. Pharmaceutical compositions comprising the inhibitors of the invention are also described. Methods of inhibiting neuraminidase in samples suspected of containing neuraminidase are also described. Antigenic materials, polymers, antibodies, conjugates of the compounds of the invention with labels, and assay methods for detecting neuraminidase activity are also described.

      供应商参考报价(招募中)

      品牌试剂参考报价(招募中)

      📌 第三方产品分析报告

      ✅ COA系统入驻 | 共享模式

      合成参考文献


      摘要:Kleemann, A.; Engel, J.; Kutscher, B.; Reichert, D., Pharmaceutical Substances[Online], Thieme: Stuttgart, (2008).
      摘要:Bräse, S.; Lesch, B.; Zimmermann, V., Science of Synthesis, (2010) 41, 605.
      📝 需求与反馈
      尽可能描述清楚需求与问题信息
      ×

      通知